Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 5/20 | 0.54 |
| ▸ | SIRT1 | Q96EB6 | 3/20 | 0.54 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4905245 | 0.93 | SIRT2 (0.51) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL11925819 | 0.91 | SIRT2 (0.53) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL11907039 | 0.91 | SIRT2 (0.53) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL11925972 | 0.89 | SIRT2 (0.52) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL11907490 | 0.89 | SIRT2 (0.52) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL7226973 | 0.87 | ANPEP (0.52) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL16846627 | 0.84 | SIRT2 (0.49) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL11907491 | 0.82 | SIRT2 (0.49) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL11925821 | 0.81 | GLP1R (0.47) | SIRT2SIRT1SIRT3CA1CA2 | |
| SCHEMBL11909269 | 0.81 | GLP1R (0.47) | SIRT2SIRT1SIRT3CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8754135-B2 | Functionalized non-phenolic amino acids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2014-06-17 | — | — | US | disclosed |
| US-8754135-B2 | Functionalized non-phenolic amino acids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2014-06-17 | — | — | US | disclosed |
| US-8754135-B2 | Functionalized non-phenolic amino acids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2014-06-17 | — | — | US | disclosed |
| US-20130317120-A1 | FUNCTIONALIZED NON-PHENOLIC AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2013-11-28 | — | — | US | disclosed |
| US-8519156-B2 | Functionalized non-phenolic amino acids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-08-27 | — | — | US | disclosed |
| US-8519156-B2 | Functionalized non-phenolic amino acids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-08-27 | — | — | US | disclosed |
| US-8519156-B2 | Functionalized non-phenolic amino acids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-08-27 | — | — | US | disclosed |
| US-20130116446-A1 | FUNCTIONALIZED NON-PHENOLIC AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2013-05-09 | — | — | US | disclosed |
| US-20130116446-A1 | FUNCTIONALIZED NON-PHENOLIC AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2013-05-09 | — | — | US | disclosed |
| US-20130116446-A1 | FUNCTIONALIZED NON-PHENOLIC AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2013-05-09 | — | — | US | disclosed |
| US-8367108-B2 | Hydrolyzable polyesters, polyurethanes, polyamideester copolymers, polyamides, and polyanhydrides; biodegradable, bioresorbable polymers for tissue engineering, implantable medical devices, and time-release drug delivery systems | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-05 | — | — | US | disclosed |
| US-8367108-B2 | Hydrolyzable polyesters, polyurethanes, polyamideester copolymers, polyamides, and polyanhydrides; biodegradable, bioresorbable polymers for tissue engineering, implantable medical devices, and time-release drug delivery systems | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-05 | — | — | US | disclosed |
| US-8367108-B2 | Hydrolyzable polyesters, polyurethanes, polyamideester copolymers, polyamides, and polyanhydrides; biodegradable, bioresorbable polymers for tissue engineering, implantable medical devices, and time-release drug delivery systems | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-05 | — | — | US | disclosed |
| US-20080057127-A1 | FUNCTIONALIZED NON-PHENOLIC AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2008-03-06 | — | — | US | disclosed |
| US-20080057127-A1 | FUNCTIONALIZED NON-PHENOLIC AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2008-03-06 | — | — | US | disclosed |
| US-20080057127-A1 | FUNCTIONALIZED NON-PHENOLIC AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2008-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130317120-A1 | FUNCTIONALIZED NON-PHENOLIC AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM | SLC1A5, SLC7A1, BCAT2 | SIRT2 3319/4885SIRT1 3096/4885SIRT3 3518/4885 |
| US-20080057127-A1 | FUNCTIONALIZED NON-PHENOLIC AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM | SLC1A5, SLC7A1, BCAT2 | SIRT2 3319/4885SIRT1 3096/4885SIRT3 3518/4885 |
| US-20130116446-A1 | FUNCTIONALIZED NON-PHENOLIC AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM | SLC1A5, SLC7A1, BCAT2 | SIRT2 3319/4885SIRT1 3096/4885SIRT3 3518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.